NS
RARE icon

NBC Securities’s Ultragenyx Pharmaceutical RARE Stock Holding History

NBC Securities’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-159
Closed -$4.78K – 2902
2025
Q3 		$4.78K Hold
159
– – ﹤0.01% 2222
2025
Q2 		$5K Hold
159
– – ﹤0.01% 2112
2025
Q1 		$5K Buy
+159
New +$6.62K ﹤0.01% 1874
2024
Q4 		– Sell
-159
Closed -$8K – 1883
2024
Q3 		$8K Hold
159
– – ﹤0.01% 1801
2024
Q2 		$6K Buy
+159
New +$6.79K ﹤0.01% 1821

Other funds holding RARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

NBC Securities's RARE Position: Q4 2025 in Review

NBC Securities sold out of Ultragenyx Pharmaceutical (RARE) in Q4 2025, closing a stake of 159 shares — an estimated $4.78K sold.

NBC Securities first reported a position in RARE in Q2 2024 and held it in 5 quarters. The position peaked at $8K in Q3 2024. 288 funds tracked by Wall St. Rank hold RARE as of Q4 2025.

  • NBC Securities reported no remaining Ultragenyx Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • NBC Securities sold 159 Ultragenyx Pharmaceutical shares in Q4 2025, an estimated $4.78K.
  • NBC Securities first reported a position in Ultragenyx Pharmaceutical in Q2 2024 and held it in 5 quarters.
  • NBC Securities's Ultragenyx Pharmaceutical position peaked at $8K in Q3 2024.
  • 288 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2025.

Based on NBC Securities's 13F filing for Q4 2025, filed 29 Jan 2026.